FDA Inspection 1270620 — Lung Bioengineering Inc.
The FDA completed an inspection of Lung Bioengineering Inc. on May 6, 2025 in Silver Spring, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 6, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Silver Spring, MD (United States)
Additional Details
Sponsor, Contract Research Organization